AUPH
Price
$11.67
Change
-$0.32 (-2.67%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
1.58B
58 days until earnings call
QURE
Price
$17.00
Change
+$0.67 (+4.10%)
Updated
Sep 2, 04:59 PM (EDT)
Capitalization
895.98M
57 days until earnings call
Interact to see
Advertisement

AUPH vs QURE

Header iconAUPH vs QURE Comparison
Open Charts AUPH vs QUREBanner chart's image
Aurinia Pharmaceuticals
Price$11.67
Change-$0.32 (-2.67%)
Volume$31.53K
Capitalization1.58B
uniQure
Price$17.00
Change+$0.67 (+4.10%)
Volume$45.15K
Capitalization895.98M
AUPH vs QURE Comparison Chart in %
Loading...
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUPH vs. QURE commentary
Sep 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUPH is a Buy and QURE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 03, 2025
Stock price -- (AUPH: $11.99 vs. QURE: $16.33)
Brand notoriety: AUPH and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUPH: 35% vs. QURE: 68%
Market capitalization -- AUPH: $1.54B vs. QURE: $933.29M
AUPH [@Biotechnology] is valued at $1.54B. QURE’s [@Biotechnology] market capitalization is $933.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $102.81B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUPH’s FA Score shows that 0 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • AUPH’s FA Score: 0 green, 5 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, AUPH is a better buy in the long-term than QURE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUPH’s TA Score shows that 2 TA indicator(s) are bullish while QURE’s TA Score has 6 bullish TA indicator(s).

  • AUPH’s TA Score: 2 bullish, 6 bearish.
  • QURE’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, QURE is a better buy in the short-term than AUPH.

Price Growth

AUPH (@Biotechnology) experienced а -2.28% price change this week, while QURE (@Biotechnology) price change was +4.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.83%. For the same industry, the average monthly price growth was +22.37%, and the average quarterly price growth was +32.94%.

Reported Earning Dates

AUPH is expected to report earnings on Oct 30, 2025.

QURE is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+6.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUPH($1.58B) has a higher market cap than QURE($896M). AUPH YTD gains are higher at: 33.519 vs. QURE (-7.531). AUPH has higher annual earnings (EBITDA): 86.5M vs. QURE (-119.56M). QURE has more cash in the bank: 377M vs. AUPH (315M). QURE has less debt than AUPH: QURE (66.7M) vs AUPH (81.8M). AUPH has higher revenues than QURE: AUPH (260M) vs QURE (14.3M).
AUPHQUREAUPH / QURE
Capitalization1.58B896M176%
EBITDA86.5M-119.56M-72%
Gain YTD33.519-7.531-445%
P/E Ratio27.88N/A-
Revenue260M14.3M1,818%
Total Cash315M377M84%
Total Debt81.8M66.7M123%
FUNDAMENTALS RATINGS
AUPH vs QURE: Fundamental Ratings
AUPH
QURE
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
78
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
50100
PRICE GROWTH RATING
1..100
3738
P/E GROWTH RATING
1..100
10091
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AUPH's Valuation (65) in the Biotechnology industry is in the same range as QURE (78). This means that AUPH’s stock grew similarly to QURE’s over the last 12 months.

AUPH's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as QURE (100). This means that AUPH’s stock grew similarly to QURE’s over the last 12 months.

AUPH's SMR Rating (50) in the Biotechnology industry is somewhat better than the same rating for QURE (100). This means that AUPH’s stock grew somewhat faster than QURE’s over the last 12 months.

AUPH's Price Growth Rating (37) in the Biotechnology industry is in the same range as QURE (38). This means that AUPH’s stock grew similarly to QURE’s over the last 12 months.

QURE's P/E Growth Rating (91) in the Biotechnology industry is in the same range as AUPH (100). This means that QURE’s stock grew similarly to AUPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AUPHQURE
RSI
ODDS (%)
Bearish Trend 5 days ago
75%
Bearish Trend 5 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 5 days ago
73%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bearish Trend 5 days ago
77%
Bullish Trend 5 days ago
79%
MACD
ODDS (%)
Bearish Trend 5 days ago
90%
Bullish Trend 5 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
78%
Bullish Trend 5 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
75%
Advances
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 15 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
85%
Aroon
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MENRX9.890.02
+0.20%
Madison Covered Call & Equity Income R6
NRAEX53.05-0.03
-0.06%
Neuberger Berman Quality Equity E
LIMAX7.65-0.07
-0.91%
Cromwell Tran Sustainable Focus Investor
BMGCX25.66-0.28
-1.08%
BlackRock Mid-Cap Growth Equity Inv C
CCWRX9.73-0.11
-1.12%
Columbia Select Large Cap Growth Inst3

AUPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUPH has been loosely correlated with SHJBF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if AUPH jumps, then SHJBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUPH
1D Price
Change %
AUPH100%
-0.75%
SHJBF - AUPH
38%
Loosely correlated
N/A
ROIV - AUPH
37%
Loosely correlated
-0.08%
QURE - AUPH
35%
Loosely correlated
+0.43%
NAMS - AUPH
34%
Loosely correlated
+0.42%
FOLD - AUPH
34%
Loosely correlated
-0.78%
More

QURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with NAMS. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then NAMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
+0.43%
NAMS - QURE
56%
Loosely correlated
+0.42%
BEAM - QURE
48%
Loosely correlated
-2.91%
MGX - QURE
45%
Loosely correlated
-6.95%
ABSI - QURE
44%
Loosely correlated
-3.24%
ACLX - QURE
43%
Loosely correlated
-1.22%
More